Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19
December 02, 2020 02:05 ET | BioNTech SE
U.K. regulator, MHRA, authorizes supply of COVID-19 mRNA vaccine for emergency supply under Regulation 174; Companies are ready to deliver the first doses to the U.K. immediatelyFirst authorization...
Pfizer und BioNTech erhalten weltweit erste Zulassung für COVID-19-Impfstoff
December 02, 2020 02:05 ET | BioNTech SE
Die britische Regulierungsbehörde MHRA genehmigt die Lieferung von COVID-19-Impfstoff zur Notfallversorgung (gemäß Verordnung 174); erste Lieferungen werden innerhalb weniger Tage im Vereinigten...
Celixir provides update on ongoing clinical programme with lead therapeutic candidate CLXR-001
July 06, 2020 09:25 ET | CELIXIR Plc
Celixir provides update on ongoing clinical programme with lead therapeutic candidate CLXR-001 First patient successfully dosed in cardiomyopathy study Stratford-upon-Avon, UK: July, 6 2019...
ORION Logo Pantone(750x266).png
Orion Biotechnology Completes Scientific Advice Meeting with MHRA
October 31, 2018 11:19 ET | Orion Biotechnology Canada Ltd
OTTAWA, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, announced today the completion of a scientific advice meeting with the Medicines...
XOMA-Logo-Final.png
XOMA Announces Significant Step Toward Initiating Pediatric Phase 2 Clinical Study for XOMA 358 in Children with Congenital Hyperinsulinism
October 19, 2016 09:00 ET | XOMA Ltd.
BERKELEY, Calif., Oct. 19, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today the United Kingdom’s...
Sucampo Receives Notice that Second Indication for AMITIZA for Opioid-Induced Constipation Is Not Approved by Medicines and Healthcare Products Regulatory Agency in U.K.
March 12, 2014 20:00 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., March 12, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP) today announced that Sucampo Pharma Europe, Ltd., its wholly owned subsidiary, has received a...